AAA
INZY
Affinity Asset Advisors’s Inozyme Pharma INZY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7M | Sell |
1,749,359
-2,118,351
| -55% | -$8.47M | 0.96% | 29 |
|
|
2025
Q1 | $3.52M | Sell |
3,867,710
-104,608
| -3% | -$95.2K | 0.34% | 43 |
|
|
2024
Q4 | $11M | Buy |
3,972,318
+1,150,000
| +41% | +$3.19M | 1.47% | 21 |
|
|
2024
Q3 | $14.8M | Sell |
2,822,318
-33,934
| -1% | -$177K | 2.01% | 14 |
|
|
2024
Q2 | $12.7M | Buy |
2,856,252
+213,733
| +8% | +$953K | 1.47% | 18 |
|
|
2024
Q1 | $20.2M | Buy |
2,642,519
+756,717
| +40% | +$5.8M | 2.51% | 9 |
|
|
2023
Q4 | $8.03M | Buy |
1,885,802
+505,950
| +37% | +$2.16M | 1.47% | 21 |
|
|
2023
Q3 | $5.8M | Buy |
1,379,852
+628,056
| +84% | +$2.64M | 1.63% | 19 |
|
|
2023
Q2 | $4.19M | Hold |
751,796
| – | – | 1.46% | 20 |
|
|
2023
Q1 | $4.31M | Buy |
751,796
+251,796
| +50% | +$1.44M | 1.42% | 20 |
|
|
2022
Q4 | $525K | Buy |
+500,000
| New | +$525K | 0.21% | 48 |
|